Nocturnal enuresis in children with allergic disease: prevalence, phenotype, and ARIA severity analysis
International Urology and Nephrology, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Basım Tarihi: 2026
- Doi Numarası: 10.1007/s11255-026-05281-3
- Dergi Adı: International Urology and Nephrology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE, Biomedical Reference Collection: Corporate Edition (EBSCO), Health Research Premium Collection (ProQuest), Pharma Collection (ProQuest)
- Anahtar Kelimeler: Primary nocturnal enuresis, Allergic rhinitis, ARIA classification, Obstructive sleep apnea, Sleep disturbance, Pediatric comorbidity
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Objective: To determine the prevalence of primary nocturnal enuresis (PNE) in children with allergic disease, characterize the allergic symptom burden in children with PNE, and identify clinical phenotype differences between allergic and nonallergic enuretic children. Methods: 300 children aged 5–18 years were enrolled in three groups: a specialist-confirmed allergic disease cohort (Group 1, n = 100), a nephrologist-confirmed PNE cohort (Group 2, n = 100), and a general pediatric comparison group (Group 3, n = 100). Clinical phenotype was systematically compared between allergic enuretic children and enuretic children from the comparison group. Allergic Rhinitis and its Impact on Asthma (ARIA) classification severity classification was applied in children with allergic rhinitis as a pre-specified exploratory analysis. Results: PNE prevalence was 1.7-fold higher in allergic children than in the comparison group (27.0% vs 16.0%; OR: 1.94, 95% CI 0.97–3.88, p = 0.060). Allergic enuretic children showed a phenotypically distinct profile: shorter enuresis duration (2.0 vs 3.0 years, p = 0.028), higher nocturnal sleep disturbance (36.0% vs. 6.7%, p = 0.060), and lower rates of stress-related exacerbation (34.6% vs. 75.0%, p = 0.025) compared with enuretic children from the comparison group. ISAAC-based screening in the PNE cohort revealed a substantial allergic symptom burden: wheezing in 45.0%, inhaler use in 33.0%, and allergic rhinitis symptoms in 22.0%. An exploratory monotonic gradient in PNE prevalence was observed across ARIA severity categories (ARIA-1: 12.5%, ARIA-2: 25.0%, ARIA-3: 33.3%; p = 0.172). Conclusions: Allergic enuretic children display a distinct sleep-associated clinical phenotype, and a notable allergic symptom burden is present in children with PNE. These findings support asking about nocturnal enuresis in allergic children and considering allergy-focused evaluation in selected PNE patients in general pediatric practice.